This article first appeared on GuruFocus.
Cerebras Systems could be emerging as one of the most closely watched artificial intelligence infrastructure listings of the year after the chipmaker raised $5.55 billion in its US initial public offering, with shares pricing at $185, above the marketed range. Investor demand for AI semiconductor exposure appeared exceptionally strong, with orders reportedly exceeding available shares by more than 20 times. The pricing gives Cerebras an implied market value of about $40 billion, or roughly $49 billion on a fully diluted basis, positioning the company among a growing group of AI chip firms attempting to challenge Nvidia Corp. in high-performance computing workloads.
The company has already established relationships with several major AI ecosystem participants that could strengthen its long-term positioning. Amazon.com said earlier this year that it plans to use Cerebras chips alongside Trainium processors to run AI software, while OpenAI released its first model operating on Cerebras chips in February. OpenAI also holds 33.4 million warrants tied partly to compute delivery milestones and Cerebras achieving a market value above $40 billion, according to the filings. Cerebras and its banking syndicate reportedly adjusted the IPO process to better measure institutional demand, asking investors to specify both share quantity and maximum pricing levels as enthusiasm around the offering accelerated.
The IPO is the largest US listing so far this year, arriving shortly before what could become an even larger technology offering if Elon Musk’s SpaceX proceeds with a potential $75 billion fundraising target this summer. Cerebras also attracted strategic interest ahead of the listing, with Arm Holdings Plc (NASDAQ:ARM) and SoftBank Group Corp. (SOBKY) reportedly approaching the company about a possible acquisition weeks before the IPO. Financially, Cerebras reported net income of $87.9 million on revenue of $510 million for 2025, compared with a net loss of $484.8 million on revenue of $290.3 million a year earlier, potentially reinforcing investor optimism around the company’s growth trajectory as shares prepare to begin trading on the Nasdaq Global Select Market under the ticker CBRS.